Form 4 Tracker
Charles J Homcy

Director · 4 filings · Latest: Jun 22, 2026

BridgeBio Pharma, Inc.
Maze Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BBIO
CHARLES J HOMCY—Aug 11, 2025
Proposed Sale
$48.0050,000$2.4M—
BBIO
CHARLES J HOMCY—Aug 8, 2025
Proposed Sale
$46.05250,000$11.5M—